Filing Details
- Accession Number:
- 0001144204-14-072155
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-03 17:04:16
- Reporting Period:
- 2014-11-26
- Filing Date:
- 2014-12-03
- Accepted Time:
- 2014-12-03 17:04:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1208261 | Immune Pharmaceuticals Inc | IMNP | Pharmaceutical Preparations (2834) | 521841431 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1506598 | Gad Berdugo | Cambridge Innovation Center One Broadway, 14Th Floor Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-11-26 | 8,000 | $2.50 | 8,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant | Acquisiton | 2014-11-26 | 2,000 | $0.00 | 2,000 | $3.75 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,000 | 2014-11-26 | 2017-11-26 | No | 4 | P | Direct |
Footnotes
- The securities were purchased by the Reporting Person in connection with the underwriter's partial exercise of its over-allotment option to purchase additional units in the Issuer's underwritten public offering that closed on November 25, 2014.